Annual report pursuant to Section 13 and 15(d)

Note 13 - Supplemental Disclosures of Cash Flow Information and Noncash Investing and Financing Activities (Details Textual)

v3.2.0.727
Note 13 - Supplemental Disclosures of Cash Flow Information and Noncash Investing and Financing Activities (Details Textual) - USD ($)
 12 Months Ended
Nov. 03, 2014
Apr. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
Novus Holdings, LLC [Member]          
Business Combination, Consideration Transferred     $ 60,122,000    
Payments to Acquire Businesses, Net of Cash Acquired     60,122,000    
ProteinSimple [Member]          
Business Combination, Consideration Transferred     300,053,000    
Payments to Acquire Businesses, Net of Cash Acquired     300,053,000    
CyVek, Inc. [Member]          
Business Combination, Consideration Transferred     94,927,000    
Payments to Acquire Businesses, Gross $ 62,000,000   62,000,000    
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High     35,000,000    
Payments to Acquire Businesses, Net of Cash Acquired     59,927,000    
PrimeGene and Bionostics [Member]          
Business Combination, Consideration Transferred       $ 103,000,000  
PrimeGene [Member]          
Business Combination, Consideration Transferred     18,761,000 18,700,000  
Payments to Acquire Businesses, Net of Cash Acquired   $ 6,000,000 6,031,000 6,000,000  
Business Combination, Consideration Transferred, Liabilities Incurred       12,700,000  
Proceeds from (Repayments of) Lines of Credit     73,000,000    
Payments to Acquire Businesses, Net of Cash Acquired     420,102,000 109,180,000 $ 0
Income Taxes Paid, Net     $ 42,600,000 $ 55,200,000 $ 51,600,000
Conversion of Stock, Shares Issued     385 1,077  
Conversion of Stock, Shares Converted     309 733  
Conversion of Stock, Amount Converted     $ 31,000 $ 56,000